Current status of glucocorticoid usage in solid organ transplantation

doi:10.5500/wjt.v11.i11.443

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6093)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

545

WORD

176

HTML

3688

Figures (1-2)

155

Tables (1-1)

164

Sum=4728

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

235

Download

319

Sum=554

Publishing Process of This Article

Item

Count

Browse

347

Download

464

Sum=811

Nov 18, 2021 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Nov 18, 2021; 11(11): 443-465
Published online Nov 18, 2021. doi: 10.5500/wjt.v11.i11.443

Open in New Tab Full Size Figure Download Figure

Figure 1 Advantages and disadvantages of glucocorticoids in solid organ transplantation. CNI: Calcineurin inhibitor; GC: Glucocorticoid; GVHD: Graft vs host disease; IRI: Ischemia-reperfusion injury; PTLD: Post-transplant lymphoproliferative disorder; SOT: Solid organ transplantation.

Open in New Tab Full Size Figure Download Figure

Figure 2 Effects of glucocorticoids on the immune system. COX2: Cyclooxygenase 2; IFN-γ: Interferon-gamma; IL: Interleukin; iNOS: Inducible nitric oxide synthase; LT: Leukotriene; NK: Natural killer; TNF-α: Tumor necrosis factor-alpha.

Citation: Dashti-Khavidaki S, Saidi R, Lu H. Current status of glucocorticoid usage in solid organ transplantation. World J Transplant 2021; 11(11): 443-465
URL: https://www.wjgnet.com/2220-3230/full/v11/i11/443.htm
DOI: https://dx.doi.org/10.5500/wjt.v11.i11.443